InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,307.88
(
0.48%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.73
(
0.36%
)
Bitcoin
61,479.27
(
-0.21%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119944
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 166998

Wednesday, 09/25/2013 2:50:56 PM

Wednesday, September 25, 2013 2:50:56 PM

Post# of 252412
WSJ’s lead paragraph on MAKO deal is a non sequitur (IMO):

http://online.wsj.com/article/SB10001424052702303796404579096981814533534.html

Stryker Corp. agreed to acquire Mako Surgical Corp. and its robotic-surgery platform for roughly $1.65 billion, a move aimed at distinguishing Stryker's line of replacement knees and hips for its increasingly cost-conscious hospital customers.

SYK’s knees don’t work any better with the MAKO procedure than ZMH’s knees or DePuy’s knees. Maybe they will at some point, but there’s no immediate technical synergy.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up